Cagent Vascular - Crunchbase Company Profile & Funding

Q: Who invested in Cagent Vascular?

Cagent Vascular has 9 investors including U.S. Venture Partners And Astoria Health Investors.

Q: When was the last funding round for Cagent Vascular?

Cagent Vascular closed its last funding round on obfuscated from a Series D round.

Q: How much funding has Cagent Vascular raised to date?

Cagent Vascular has raised obfuscated.

Overview

Cagent Vascular

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Cagent Vascular

CB Rank

1370

Cagent Vascular develops a serration technology for improving the treatment of cardiovascular disease.

Founded

obfuscation

Private

Series D

Wayne, Pennsylvania, United States

11-50

www.cagentvascular.com

Health Care

Medical

Medical Device

Funding Rounds

Series D

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Series C

OBF

obfuscation

Key People

Robert M. Giasolli: Founder, CTO, and VP of Research and Development
Past Role: Intact Vascular, CTO/Co-founder
Peter Schneider: Chief Medical Officer, Co-Founder

Details

Legal Name

Cagent Vascular, LLC

Operating Status

Active

Company Type

For Profit

Founders

Carol Burns, Peter Johansson, Peter Schneider, Robert M. Giasolli

About the Company

Cagent Vascular develops a serration technology for improving the treatment of cardiovascular disease. Its commercialized angioplasty balloon with serration technology treats blocked arteries in the leg or peripheral artery disease and chronic limb-threatening ischemia.

Phone Number

610-688-2006

Contact Email

info@cagentvascular.com

Diversity Spotlight

Women Founded

Women Led

Predictions & Insights

Growth Insight

See this Growth Insight

Cagent Vascular is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

Serranator PTA Serration Balloon Catheter

A balloon catheter with serrated metal strips that applies point force to arteries during angioplasty, enabling controlled lumen expansion at lower pressures.

Serranator SL-PRO

A specialized serration balloon product designed for treating chronic limb-threatening ischemia (CLTI) and pedal artery disease.

Research & Development

Cagent Vascular is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series D - Cagent Vascular	2	obfuscated obfuscation	Astoria Health Investors, U.S. Venture Partners	Series D
obfuscated obfuscation	Series D - Cagent Vascular	2	obfuscated obfuscation	Astoria Health Investors, U.S. Venture Partners	Series D
obfuscated obfuscation	Series D - Cagent Vascular	2	obfuscated obfuscation	Astoria Health Investors, U.S. Venture Partners	Series D
obfuscated obfuscation	Series D - Cagent Vascular	2	obfuscated obfuscation	Astoria Health Investors, U.S. Venture Partners	Series D
obfuscated obfuscation	Series D - Cagent Vascular	2	obfuscated obfuscation	Astoria Health Investors, U.S. Venture Partners	Series D

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series D - Cagent Vascular	2	obfuscated obfuscation	Astoria Health Investors, U.S. Venture Partners	Series D
obfuscated obfuscation	Series D - Cagent Vascular	2	obfuscated obfuscation	Astoria Health Investors, U.S. Venture Partners	Series D
obfuscated obfuscation	Series D - Cagent Vascular	2	obfuscated obfuscation	Astoria Health Investors, U.S. Venture Partners	Series D
obfuscated obfuscation	Series D - Cagent Vascular	2	obfuscated obfuscation	Astoria Health Investors, U.S. Venture Partners	Series D
obfuscated obfuscation	Series D - Cagent Vascular	2	obfuscated obfuscation	Astoria Health Investors, U.S. Venture Partners	Series D

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
U.S. Venture Partners	Yes	Series D - Cagent Vascular	Casey Tansey
U.S. Venture Partners	Yes	Series D - Cagent Vascular	Casey Tansey
U.S. Venture Partners	Yes	Series D - Cagent Vascular	Casey Tansey
U.S. Venture Partners	Yes	Series D - Cagent Vascular	Casey Tansey
U.S. Venture Partners	Yes	Series D - Cagent Vascular	Casey Tansey